geraniol and B16 Melanoma

geraniol has been researched along with B16 Melanoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elson, CE; Hildebrandt, LA; Yu, SG1
Elson, CE; Jung, M; Mo, H; Tatman, D1
Elson, CE; Grummer, M; Shoff, SM; Yatvin, MB1

Other Studies

3 other study(ies) available for geraniol and B16 Melanoma

ArticleYear
Geraniol, an inhibitor of mevalonate biosynthesis, suppresses the growth of hepatomas and melanomas transplanted to rats and mice.
    The Journal of nutrition, 1995, Volume: 125, Issue:11

    Topics: Acyclic Monoterpenes; Animals; Dose-Response Relationship, Drug; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Neoplasms, Experimental; Male; Melanoma, Experimental; Mevalonic Acid; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Rats; Rats, Inbred BUF; Skin Neoplasms; Terpenes; Tumor Cells, Cultured

1995
Farnesyl anthranilate suppresses the growth, in vitro and in vivo, of murine B16 melanomas.
    Cancer letters, 2000, Sep-01, Volume: 157, Issue:2

    Topics: Acyclic Monoterpenes; Analysis of Variance; Animals; Antineoplastic Agents; Apoptosis; Cell Division; Cholesterol; Dose-Response Relationship, Drug; Farnesol; Melanoma, Experimental; Mice; ortho-Aminobenzoates; Terpenes; Tumor Cells, Cultured

2000
Concentration-dependent increase of murine P388 and B16 population doubling time by the acyclic monoterpene geraniol.
    Cancer research, 1991, Jan-01, Volume: 51, Issue:1

    Topics: Acyclic Monoterpenes; Animals; Cell Division; Growth Inhibitors; Leukemia, Experimental; Melanoma, Experimental; Mevalonic Acid; Mice; Survival Analysis; Terpenes; Tumor Cells, Cultured

1991